These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 31996054

  • 1. Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans.
    Lian W, Nie H, Yuan Y, Wang K, Chen W, Ding L.
    J Invest Surg; 2021 Jul; 34(7):765-770. PubMed ID: 31996054
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial.
    Yao W, Wang L, Chen Q, Wang F, Feng N.
    Med Sci Monit; 2020 Jun 16; 26():e919977. PubMed ID: 32541643
    [Abstract] [Full Text] [Related]

  • 4. Endothelin-1 and C Reactive Protein as Potential Biomarkers for Restenosis in Patients with Arteriosclerosis Obliterans.
    Rencüzoğulları I, Çınar T, Karabağ Y.
    J Invest Surg; 2021 Jul 16; 34(7):771-772. PubMed ID: 32000546
    [No Abstract] [Full Text] [Related]

  • 5. Systemic Immune-Inflammation Index Predicts Restenosis after Interventions for Lower Extremity Arteriosclerosis Obliterans.
    Tian SY.
    Heart Surg Forum; 2023 May 31; 26(3):E225-E233. PubMed ID: 37401437
    [Abstract] [Full Text] [Related]

  • 6. The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis.
    Yang B, Xiaping Z.
    Front Surg; 2022 May 31; 9():1031108. PubMed ID: 36704514
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients.
    Li H, Gui H, Yuan G, Zheng X, Gao C, Yuan H.
    Scand J Clin Lab Invest; 2018 Jul 31; 78(4):269-274. PubMed ID: 29553861
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Randomized controlled trial to superficial femoral artery recanalization for lower extremity arteriosclerosis obliterans].
    Zhuang JM, Li X, Li TR, Zhao J, Luan JY, Wang CM.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Feb 18; 49(1):153-7. PubMed ID: 28203023
    [Abstract] [Full Text] [Related]

  • 13. [Morphologic changes in the arterial wall in restenosis after reconstructive and endovascular interventions].
    Shval'b PG, Kalinin RE, Ukhov IuI, Alferov IuV, Levitin AV.
    Arkh Patol; 2008 Feb 18; 70(1):42-4. PubMed ID: 18368808
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Analysis of clinical state for arteriosclerosis obliterans in lower extremity of diabetic patients on peritoneal dialysis].
    Shi JB, Sun QH, Nie JD, Sun LH, Zhang N, Han QF.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Feb 18; 45(1):109-13. PubMed ID: 23411531
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease.
    Guo B, Tan Q, Guo D, Shi Z, Zhang C, Guo W.
    J Vasc Surg; 2014 Oct 18; 60(4):993-1001. PubMed ID: 24877854
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
    Dibra A, Mehilli J, Braun S, Hadamitzky M, Baum H, Dirschinger J, Schühlen H, Schömig A, Kastrati A.
    Am Heart J; 2005 Aug 18; 150(2):344-50. PubMed ID: 16086941
    [Abstract] [Full Text] [Related]

  • 19. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A, Wojakowski W, Dzielski T, Milewski K, Gościńska-Bis K, Tendera M, Buszman P.
    Kardiol Pol; 2009 Jun 18; 67(6):623-30. PubMed ID: 19618318
    [Abstract] [Full Text] [Related]

  • 20. Application of a rehabilitation management strategy based on symptom management theory in postoperative functional exercises in patients with lower extremity arteriosclerosis obliterans.
    Yuan Y, Chen J, Wang X, Song J.
    Technol Health Care; 2024 Jun 18; 32(1):63-73. PubMed ID: 37248923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.